Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Corvus Pharma Com (CRVS)

Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Corvus: Q4 Earnings Snapshot AP - Tue Mar 19, 3:15PM CDT

Corvus: Q4 Earnings Snapshot

CRVS : 1.4000 (-0.71%)
Corvus: Q3 Earnings Snapshot AP - Tue Nov 7, 2023

Corvus: Q3 Earnings Snapshot

CRVS : 1.4000 (-0.71%)
Corvus: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Corvus: Q2 Earnings Snapshot

CRVS : 1.4000 (-0.71%)
Corvus: Q1 Earnings Snapshot AP - Mon May 8, 2023

Corvus: Q1 Earnings Snapshot

CRVS : 1.4000 (-0.71%)
Corvus: Q4 Earnings Snapshot AP - Tue Mar 28, 2023

Corvus: Q4 Earnings Snapshot

CRVS : 1.4000 (-0.71%)
Corvus: Q3 Earnings Snapshot AP - Thu Nov 3, 2022

Corvus: Q3 Earnings Snapshot

CRVS : 1.4000 (-0.71%)
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results Globe Newswire - Mon Aug 8, 2022

Prioritizing Development of CPI-818 for T Cell Lymphomas, Autoimmune and Allergic Diseases Plans to Begin Phase 2 Clinical Trial of Ciforadenant in...

CRVS : 1.4000 (-0.71%)
Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research Globe Newswire - Thu Jul 21, 2022

BURLINGAME, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Corvus or the Company) (Nasdaq: CRVS), a clinical-stage...

CRVS : 1.4000 (-0.71%)
Corvus Pharmaceuticals Provides Program Updates at R&D Symposium Globe Newswire - Tue May 10, 2022

Highlights new interim data from CPI-818 Phase 1/1b study in patients with relapsed T cell lymphomas Program covers scientific rationale, preclinical...

CRVS : 1.4000 (-0.71%)
Corvus Pharmaceuticals to Host R&D Symposium on May 10, 2022 in New York Globe Newswire - Tue Apr 26, 2022

Company to host a webcast at 9:00am ET / 6:00am PT...

CRVS : 1.4000 (-0.71%)

Barchart Exclusives

Dividend Newcomers: Discover 3 Companies Starting To Share the Wealth Barchart - Fri Apr 19, 6:00PM CDT
Discover the potential of newly initiated dividends—start building your wealth with tomorrow's top dividend payers today! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot